With over 30 years of experience in the pharmaceutical industry, Patrick DePalma brings a wealth of expertise in Research & Development, Quality Assurance, and Business Development, particularly in the CDMO space with a focus on complex biologics and advanced therapies, states NorthX.

Patrick DePalma

Patrick DePalma has held several leadership roles at different organizations, including Emergent, Vigene/Charles River, and Advaxia Biologics, where he drove business growth and forged strategic partnerships. His academic credentials include a Bachelor of Science (ACS-accredited) and a Master of Science in Analytical Chemistry (LC/MS) from Clemson University.

“NorthX Biologics offers an outstanding portfolio of services, from microbial and mammalian recombinant proteins to viral products, mRNA, plasmids, cell therapy, and extracellular vesicles. The company’s reputation as a trusted partner and its commitment to its ‘Beyond CDMO’ approach make this an exciting time to join. I look forward to collaborating with the team to support our clients in delivering life-changing therapies to patients globally,” says Patrick DePalma.